1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet Lond Engl 2020; 395: 497–506.
2. Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020; 16: 747–764.
3. Zheng Y-Y, Ma Y-T, Zhang J-Y, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17: 259–260.
4. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA 2020; 323: 1061–1069.
5. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. Epub ahead of print 22 April 2020. DOI: 10.1001/jama.2020.6775.
6. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. Epub ahead of print 25 March 2020. DOI: 10.1001/jamacardio.2020.0950.
7. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Epub ahead of print 27 March 2020. DOI: 10.1001/jamacardio.2020.1017.
8. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. Epub ahead of print 10 March 2020. DOI: 10.1016/j.pcad.2020.03.001.
9. Poterucha Timothy J., Elias Pierre, Jain Sneha S., et al. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19. J Am Heart Assoc 2021; 10: e018476.
10. Maeda T, Obata R, Rizk D, et al. Cardiac Injury and Outcomes of Patients with COVID-19 in New York City. Heart Lung Circ. Epub ahead of print 23 November 2020. DOI: 10.1016/j.hlc.2020.10.025.
11. Lala A, Johnson KW, Januzzi JL, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol 2020; 76: 533–546.
12. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420–422.
13. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. DOI: 10.1001/jamacardio.2020.3557.
14. Meyer P, Degrauwe S, Van Delden C, et al. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J 2020; 41: 1860.
15. Einthoven W, de Lint K. Ueber das normale menschliche Elektrokardiogramm und über die capillar-elektrometrische Untersuchung einiger Herzkranken. Arch Für Gesamte Physiol Menschen Tiere 1900; 80: 139–160.
16. Goldstein B. Intensive Care Unit ECG Monitoring. Card Electrophysiol Rev 1997; 1: 308–310.
17. He J, Wu B, Chen Y, et al. Characteristic Electrocardiographic Manifestations in Patients With COVID-19. Can J Cardiol. Epub ahead of print 29 March 2020. DOI: 10.1016/j.cjca.2020.03.028.
18. Doyen D, Moceri P, Ducreux D, et al. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. The Lancet; 0. Epub ahead of print 23 April 2020. DOI: 10.1016/S0140-6736(20)30912-0.
19. Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 — A Case Series. N Engl J Med 2020; 0: null.
20. Mp A, Ey W, Mp W, et al. Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort. Journal of cardiovascular electrophysiology. Epub ahead of print 10 June 2020. DOI: 10.1111/jce.14772.
21. Sa M, P G, U K, et al. Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes. Journal of cardiac failure; 26. Epub ahead of print July 2020. DOI: 10.1016/j.cardfail.2020.06.005.
22. Barman HA, Atici A, Alici G, et al. The effect of the severity COVID-19 infection on electrocardiography. Am J Emerg Med; 0. Epub ahead of print 7 October 2020. DOI: 10.1016/j.ajem.2020.10.005.
23. Elias P, Poterucha TJ, Jain SS, et al. The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19. Mayo Clin Proc 2020; 95: 2099–2109.
24. Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement. Europace. Epub ahead of print 18 September 2020. DOI: 10.1093/europace/euaa258.
25. Luther T, Bülow‐Anderberg S, Larsson A, et al. COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury. Acta Anaesthesiol Scand; n/a. DOI: https://doi.org/10.1111/aas.13746.
26. Mason JW, Hancock EW, Gettes LS. Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part II: Electrocardiography Diagnostic Statement List A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2007; 49: 1128–1135.
27. Bazett HC. An Analysis of the Time-Relations of Electrocardiograms. Ann Noninvasive Electrocardiol 1997; 2: 177–194.
28. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019; 40: 237–269.
29. Zema MJ, Collins M, Alonso DR, et al. Electrocardiographic Poor R-Wave Progression: Correlation with Postmortem Findings. CHEST 1981; 79: 195–200.
30. Anttila IJT, Nikus KC, Lehtimaki T, et al. Relation of poor R-wave progression to risk of cardiovascular mortality. Eur Heart J; 34. Epub ahead of print 1 August 2013. DOI: 10.1093/eurheartj/eht308.P1540.
31. Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part IV: The ST Segment, T and U Waves, and the QT Interval A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009; 53: 982–991.
32. Moreno RP, Metnitz PGH, Almeida E, et al. SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 2005; 31: 1345–1355.
33. Giustino G, Croft LB, Stefanini GG, et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol 2020; 76: 2043–2055.
34. DeFilippis Andrew P., Chapman Andrew R., Mills Nicholas L., et al. Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. Circulation 2019; 140: 1661–1678.
35. Bavishi C, Bonow RO, Trivedi V, et al. Special Article - Acute myocardial injury in patients hospitalized with COVID-19 infection: A review. Prog Cardiovasc Dis 2020; 63: 682–689.
36. Pellegrini Dario, Kawakami Rika, Guagliumi Giulio, et al. Microthrombi as a Major Cause of Cardiac Injury in COVID-19. Circulation 2021; 143: 1031–1042.
37. Js H, Ch S, My C, et al. Coronavirus-induced myocarditis: A meta-summary of cases. Heart & lung : the journal of critical care; 49. Epub ahead of print December 2020. DOI: 10.1016/j.hrtlng.2020.08.013.
38. Buttà C, Zappia L, Laterra G, et al. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: A comprehensive review. Ann Noninvasive Electrocardiol 2020; 25: e12726.
39. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail; n/a. DOI: 10.1002/ejhf.1828.
40. Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. Epub ahead of print 13 May 2020. DOI: 10.1056/NEJMc2011400.
41. Malas MB, Naazie IN, Elsayed N, et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine; 29. Epub ahead of print 1 December 2020. DOI: 10.1016/j.eclinm.2020.100639.
42. Kho J, Ioannou A, Van den Abbeele K, et al. Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications. Am J Emerg Med 2020; 38: 2142–2146.
43. Dam LF van, Kroft LJM, Wal LI van der, et al. Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thromb Res 2020; 193: 86–89.
44. Longchamp G, Manzocchi-Besson S, Longchamp A, et al. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis. Thromb J 2021; 19: 15.
45. Bergamaschi L, D’Angelo EC, Paolisso P, et al. The value of ECG changes in risk stratification of COVID-19 patients. Ann Noninvasive Electrocardiol; n/a: e12815.
46. Hultstöm M, von Seth M, Frithiof R. Hyperreninemia and low total body water may contribute to acute kidney injury in corona virus disease 2019 patients in intensive care. J Hypertens. Epub ahead of print 28 May 2020. DOI: 10.1097/HJH.0000000000002531.
47. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020; 395: 1054–1062.
48. Li Dongze, Chen You, Jia Yu, et al. SARS-CoV-2–Induced Immune Dysregulation and Myocardial Injury Risk in China. Circ Res 2020; 127: 397–399.